Gefitinib Genepharm

Gefitinib Genepharm is an oral medication used for targeted cancer therapy. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth, offering a precise approach to treatment.

Gefitinib Genepharm is primarily used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC). It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC with specific EGFR mutations.

Common effects of Gefitinib Genepharm may include skin rash, diarrhea, and fatigue. Some users might experience nausea or appetite loss. These effects can vary in intensity and duration, and it's important to monitor any persistent or severe symptoms.

Gefitinib Genepharm should be handled with care, following the guidance of a healthcare professional. It is essential to inform your doctor about any pre-existing conditions or other medications you are taking. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider.

Gefitinib Genepharm may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit or grapefruit juice, as they can affect the metabolism of Gefitinib. Always consult your healthcare provider before starting or stopping any medication.